Yonsei University
š°š·South Korea
- Country
- š°š·South Korea
- Ownership
- Private
- Established
- 1885-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.yonsei.ac.kr
A Cohort Study in Korean Patients With Chronic Hepatitis B (CHB) Receiving Pegylated Interferon
Completed
- Conditions
- Chronic Hepatitis B
- Interventions
- Drug: pegylated Interferon-alpha 2a
- First Posted Date
- 2012-02-10
- Last Posted Date
- 2016-08-17
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 500
- Registration Number
- NCT01531166
- Locations
- š°š·
Sang Hoon Ahn, Seoul, Seodaemun-gu, Korea, Republic of
A Comparison Between Propofol-Remifentanil and Midazolam-Remifentanil Sedation in the Intensive Care Unit
- First Posted Date
- 2012-02-07
- Last Posted Date
- 2016-08-17
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 77
- Registration Number
- NCT01527903
- Locations
- š°š·
Severance Hospital, Seoul, Korea, Republic of
Study of BKM120 in Advanced Squamous Cell Carcinoma of Head and Neck
Phase 2
- Conditions
- Head Neck Cancer Squamous Cell MetastaticHead Neck Cancer Squamous Cell Recurrent
- Interventions
- First Posted Date
- 2012-02-07
- Last Posted Date
- 2012-10-08
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 53
- Registration Number
- NCT01527877
- Locations
- š°š·
Severance Hospital, Seoul, Korea, Republic of
Effect of Intravenous Patient-controlled Analgesia (IV-PCA) With Fentanyl in Adults for Acute Postoperative Pain Control
- Conditions
- NauseaVomiting
- First Posted Date
- 2012-02-07
- Last Posted Date
- 2012-02-07
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 2000
- Registration Number
- NCT01527890
- Locations
- š°š·
Gangnam Severance Hospital, Seoul, Korea, Republic of
Effect of Single-dose Dexmedetomidine on Emergence Excitement in Adults With Nasotracheal Intubation After Orthognathic Surgery
- First Posted Date
- 2012-02-02
- Last Posted Date
- 2015-02-06
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 74
- Registration Number
- NCT01524367
- Locations
- š°š·
Gangnam severance hospital, Seoul, Korea, Republic of
Patient Satisfaction With Novel Double Pants Compared to Conventional Single Pants for Outpatient Colonoscopy
Not Applicable
- Conditions
- Colonoscopy
- Interventions
- Procedure: Pants for colonoscopy
- First Posted Date
- 2012-02-01
- Last Posted Date
- 2012-02-01
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 160
- Registration Number
- NCT01524042
- Locations
- š°š·
Soo Jung Park, Seoul, Korea, Republic of
The Effect of Dexmedetomidine on Decreasing Emergence Agitation and Delirium in Pediatric Patients Undergoing Strabismus Surgery
- First Posted Date
- 2012-01-19
- Last Posted Date
- 2015-07-16
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 88
- Registration Number
- NCT01512355
- Locations
- š°š·
Severance Hospital, Seoul, Korea, Republic of
The Beneficial Role of Percutaneous Coronary Intervention Over Optimal Medical Therapy in Elderly Patients With Coronary Artery Disease
Phase 4
- Conditions
- Coronary Artery Disease
- Interventions
- Device: Everolimus Eluting Stent or Zotalolimus Eluting StentDrug: ARB, CCB, ACE-inhibitor, statin, Nitrate, Antiplate etc.
- First Posted Date
- 2012-01-12
- Last Posted Date
- 2012-01-12
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 1600
- Registration Number
- NCT01508663
- Locations
- š°š·
Myeong-Ki, Hong, Seoul, Korea, Republic of
Comparison Between Propofol and Fentanyl for Prevention of Emergence Agitation in Children After Sevoflurane Anesthesia
Not Applicable
Completed
- Conditions
- Emergence Agitation
- Interventions
- First Posted Date
- 2012-01-10
- Last Posted Date
- 2015-07-16
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 222
- Registration Number
- NCT01506622
- Locations
- š°š·
Yonsei University, Seoul, Korea, Republic of
Neointimal Coverage After Implantation of Biolimus Eluting Stent With Biodegradable Polymer: Optical Coherence Tomographic Assessment According to the Treatment of Dyslipidemia and Hypertension and the Types of Implanted Drug-eluting Stents
Phase 4
Completed
- Conditions
- Stable Angina or Acute Coronary Syndrome Considered for Percutaneous Coronary Intervention With Dyslipidemia or Hypertension
- Interventions
- Device: Sirolimus-eluting stentDevice: Biolimus-eluting stentsDrug: Non-ARB /day after DES implantationDrug: Eposartan 600mg/day after DES implantation
- First Posted Date
- 2012-01-02
- Last Posted Date
- 2016-07-27
- Lead Sponsor
- Yonsei University
- Target Recruit Count
- 120
- Registration Number
- NCT01502904
- Locations
- š°š·
Severance Hospital, Seoul, Korea, Republic of
Ā© Copyright 2025. All Rights Reserved by MedPath